Apathy drug candidate completed Ph 1 in elderly adults Positive PK, safety and tolerability data confirmed 2nd Ph 1 in younger adults to finish in H1'25
ANNONS
IRL757 finishes Ph 1 in 65+ healthy adults
Today IRLAB announced positive topline results from IRL757 in healthy adults aged 65 and older. Most importantly, the study confirmed the drug candidate's favourable PK, safety and tolerability profile observed already in part 1 of the study in healthy younger adults. The study was part of the collaboration with MSRD.
